Perfil
Ronald G.
Crystal is the founder of GenVec, Inc. (1992), Xylocor Therapeutics, Inc. (2013), and Lexeo Therapeutics, Inc. (2017).
At Xylocor Therapeutics, Inc., he holds the title of Director.
Dr. Crystal is currently the Chairman of Genetic Medicine at Weill Cornell Medical College.
Crystal is also the founder of Annapurna Therapeutics SAS.
Cargos activos de Ronald Crystal
| Empresas | Cargo | Inicio |
|---|---|---|
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Fundador | 01/01/2013 |
Antiguos cargos conocidos de Ronald Crystal.
| Empresas | Cargo | Fin |
|---|---|---|
| GENVEC INC | Fundador | - |
| LEXEO THERAPEUTICS, INC. | Fundador | - |
Annapurna Therapeutics SAS
Annapurna Therapeutics SAS BiotechnologyHealth Technology Operates as a gene therapy company | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
GenVec, Inc.
GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Annapurna Therapeutics SAS
Annapurna Therapeutics SAS BiotechnologyHealth Technology Operates as a gene therapy company | Health Technology |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
Lexeo Therapeutics Inc
Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
- Bolsa de valores
- Insiders
- Ronald Crystal
















